Cardioprotection of cariporide evaluated by plasma myoglobin and troponin I in myocardial infarction in pigs

Fundamental and Clinical Pharmacology

Volumn 20, Issue 2, 2006, Pages 105-113

  Létienne, Robert ^a   Bel, Lydia ^a   Bessac, Anne Marie ^a   Denais, Delphine ^a   Degryse, Anne Dominique ^a   John, Gareth W ^a   Le Grand, Bruno ^a  

^a INSTITUT DE RECHERCHE PIERRE FABRE   (France)

Author keywords

Ischaemia reperfusion; Myocardial infarction; Myoglobin; troponin I

Indexed keywords

CARIPORIDE; MYOGLOBIN; TROPONIN I;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY CIRCUMFLEX BRANCH; DISEASE ASSOCIATION; DISEASE MARKER; DRUG EFFECT; HEART INFARCTION; HEART INFARCTION SIZE; HEART MUSCLE BLOOD FLOW; HEART MUSCLE ISCHEMIA; HEART MUSCLE NECROSIS; HEART MUSCLE REPERFUSION; HEART PROTECTION; HEART RATE; HEMODYNAMICS; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PREDICTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SWINE; TREATMENT OUTCOME;

ANIMALS; BIOLOGICAL MARKERS; CARDIOTONIC AGENTS; GUANIDINES; MALE; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION; MYOGLOBIN; SULFONES; SWINE; TROPONIN I;

EID: 33645296576     PISSN: 07673981     EISSN: 14728206     Source Type: Journal    
DOI: 10.1111/j.1472-8206.2006.00394.x     Document Type: Article

References (31)

1. Scholz W. Albus U. Counillon L. et al. Protective effects of HOE642, a selective sodium-hydrogen exchange subtype 1 inhibitor, on cardiac ischaemia and reperfusion Cardiovasc. Res. 1995 29 260 268
2. + exchange Cardiovasc. Res. 1997 35 80 89
3. Karmazyn M. Role of sodium-hydrogen exchange in mediating myocardial ischemic and reperfusion injury: mechanism and therapeutic implications in Fliegel L. Ed. The Na+/H+ exchanger RG Landes Co and Chapman & Hall Austin, Tex 1996 pp 189 215
4. +-exchange inhibition in regionally ischemic, reperfused porcine hearts J. Cardiovasc. Pharmacol. 1997 30 235 240
5. + exchange inhibitor Hoe 642: difference from preconditioning in the role of protein kinase C J. Am. Coll. Cardiol. 1997 29 693 701
6. Tritto F.P. Inserte J. Garcia-Dorado D. et al. Sodium/hydrogen exchanger inhibition reduces myocardial reperfusion edema after normothermic cardioplegia J. Thorac. Cardiovasc. Surg. 1998 115 709 715
7. Fox K.A. Birkhead J. Wilcox R. et al. British cardiac society working group on the definition of myocardial infarction Ann. Clin. Biochem. 2004 41 263 271
8. Lewandrowski K. Chen A. Januzzi J. Cardiac markers for myocardial infarction. A brief review Am. J. Clin. Pathol. 2002 118 S93 S99
9. Adams J.E. Miracle V.A. Cardiac biomarkers: past, present, and future Am. J. Crit. Care 1998 7 418 423
10. Collinson P.O. Boa F.G. Gaze D.C. Measurement of cardiac troponins Ann. Clin. Biochem. 2001 38 423 449
11. Hamm C.W. Acute coronary syndromes. The diagnostic role of troponins Thromb. Res. 2001 103 S63 S69
12. Hasdai D. Behar S. Boyko V. et al. Cardiac biomarkers and acute coronary syndromes - the euro heart survey of acute coronary syndromes experience Eur. Heart. J. 2003 24 1189 1194
13. Bohle R.M. Pich S. Klein H.H. Modulation of the inflammatory response in experimental myocardial infarction Eur. Heart. J. 1991 12 Suppl. D28 D31
14. 1- receptor induced late preconditioning and myocardial infarction: reperfusion duration is critical Am. J. Physiol. 2002 283 H38 H43
15. Chien G.L. Anselone C.G. Davis R.F. et al. Fluorescent vs. radioactive microsphere measurement of regional myocardial blood flow Cardiovasc. Res. 1995 30 405 412
16. Glenny R.W. Bernard S. Brinkley M. Validation of fluorescent-labeled microspheres for measurement of regional organ perfusion J. Appl. Physiol. 1993 74 2585 2597
17. Baller D. Zipfel J. Hellige G. Usefulness and limitations of myocardial oxygen consumption indices Clin. Cardiol. 1980 3 212 213
18. Tallarida R.J. Murray R.B. Area under a curve: Trapezoidal and Simpson's rules, in Donnelley R.R. Ed. Manual of pharmacologic calculations with computer programs Springer-Verlag New York Inc 1987 pp 77 81
19. Savage R.M. Guth B. White F.C. et al. Correlation of regional myocardial blood flow and function with myocardial infarct size during acute myocardial ischaemia in the conscious pig Circulation 1981 64 699 707
20. Kersten J.R. Schmeling T.J. Pagel P.S. et al. Isoflurane mimics ischemic preconditioning via activation of K(ATP) channels: reduction of myocardial infarct size with an acute memory phase Anesthesiology 1997 87 361 370
21. Varki A.P. Roby D.S. Watts H. et al. Serum myoglobin in acute myocardial infarction: a clinical study and review of the literature Am. Heart. J. 1978 96 680 688
22. Vaidya H.C. Myoglobin Lab. Med. 1992 23 306 310
23. Brianzoni E. Centioni G. Berbellini A. et al. Serum myoglobin behaviour in athletes. (Abstract) Eur. J. Nucl. Med. 1981 6 23A6
24. Kiessling W.R. Ricker K. Pflughaupt K.W. et al. Serum myoglobin in primary and secondary skeletal muscle disorders J. Neurol. 1981 224 229 333
25. Roberts R. Myoglobinemia as an index to myocardial infarction Ann. Intern. Med. 1977 87 788 789
26. Baadsgaard O. Schmidt J.F. Myoglobin concentration, creatine kinase and creatine kinase subunit B activity in serum after myocardial ischaemia Scand. J. Clin. Lab. Invest. 1984 44 679 682
27. Solaro R.J. Rarick H.M. Troponin and tropomyosin: proteins that switch on and tune in the activity of cardiac myofilaments Circ. Res. 1998 83 471 480
28. Newby L.K. Gibler W.B. Christenson R.H. et al. Serum markers for diagnosis and risk stratification in acute coronary syndromes in Cannon C.P. Ed. Management of acute coronary syndromes Human Press Inc. Totowa, NJ 2003 pp 183 210
29. Vallins W.J. Brand N.J. Dabhade N. et al. Molecular cloning of human cardiac troponin I using polymerase chain reaction FEBS. Lett. 1990 270 57 61
30. Bhayana V. Gougoulias T. Cohoe S. et al. Discordance between results for serum troponin T and troponin I in renal disease Clin. Chem. 1995 41 1671 1673
31. Bhayana V. Henderson R. Biochemical markers of myocardial damage Clin. Biochem. 1995 28 1 29